PHIGENIX, Inc. will leverage licensed patented technology to establish a strong first-mover advantage in Personalized Medicine and forge a lasting leadership position in the rapidly evolving cancer diagnostic and therapeutics industry. The PHIGENIX technology platform involves detecting and targeting the PAX2 andEN2 oncogenes for cancer diagnosis and treatment. We are currently developing diagnostic tests which may detect prostate abnormalities at the pre-malignant state years before the onset of cancer.
Phigenix Pharmaceutical
- Core Digital Health Company - Medical Device
Offering Types
- Diagnostic & Screening
- Disease Management & Therapeutics
- Clinical Research / Trials / Testing
Segments Served
- Pharmaceutical Companies
Locations
CEO Contact Information
Carlton
Donald
Founder, President, CEO
Last updated on 09/22/2023
Verified by Phigenix Pharmaceutical On 09/22/2023